Multiple Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
BMS-820132 is an investigational new drug being developed by BMS for treating Type 2 diabetes. The purpose of this study is to test the safety/tolerability (potential side effects) of multiple doses of the investigational new drug, as well as the amount of study drug in the blood and its effects on blood sugar,in subjects with type 2 diabetes.
Epistemonikos ID: 47ffe4b3818cf3f48f6ceaa1e8d08e5cba200fa9
First added on: May 06, 2024